Mochida Pharmaceutical Co., Ltd.
Notice Regarding Status of Treasury Stock Acquisition
Target is the company's common shares, total number acquired 86,100 shares, total acquisition amount 275,410,500 yen, period 2026/10/1-2026/10/31, method market purchase. For reference, cumulative total under the previous resolution is 412,000 shares, total amount 1,330,313,500 yen.
Key Figures
- 86,100 shares: Number of shares acquired
- 275,410,500 yen: Total acquisition amount
- October 1, 2026～October 31, 2026: Acquisition period
- 412,000 shares: Cumulative number of shares acquired (as of 2026/10/31)
AI要約
Current Status of Treasury Stock Acquisition
The Company continues its treasury stock acquisition program and, in this instance, conducted market purchases of common shares targeting 86,100 shares with a total acquisition amount of 275,410,500 yen. The acquisition period was from October 1, 2026 to October 31, 2026, and the cumulative number of acquired shares stood at 412,000 shares as of October 31, 2026. At the time of the previous board resolution, an upper limit of 530,000 shares (1.50% of total outstanding shares) and a total amount of 2,000,000,000 yen were established, with the period set from May 18, 2026 to December 18, 2026.
Impact on Investors and Future Outlook
Treasury stock acquisition is positioned as part of efforts to improve capital efficiency and return value to shareholders, and may contribute to enhancing shareholder value by mitigating dilution. The latest acquisition status is subject to market conditions, and some or all planned acquisitions may not be executed; therefore, continued attention to future acquisition activity is required.
Mochida Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
